Башкы Биз жөнүндө Кызматтар Байланыштар
 

Revenue Decline, Liquidity

Revenue Decline, Liquidity

Ocular’s financial performance for FY 2025 shows a revenue decline of nearly 18.7 %, with a net loss of close to $265.9 million and a net margin of approximately -513.2 %. Commercial revenue is concentrated through three specialty distributors, accounting for roughly 75 % of FY 2025 revenue, creating a risk of inconsistent revenue growth. Despite these challenges, the company holds significant liquid assets to cover short‑term debts, with a current ratio of nearly 15.4×.
18/06/2026 | Ocular Therapeutix, Inc.